weight loss
Conditions
Interventions
Two groups will be randomized, and administered in a double-blind manner, with 15 subjects in the placebo group and 15 in the Capsiate group. Participants should intake 12 mg/day of Capsiate or Placeb
G07.203.300.456
Sponsors
Universidade Federal do Piauí
Universidade Federal do Piauí
Eligibility
Sex/Gender
Male
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Men aged between 18 and 35 years; healthy; untrained for resistance training and without chronic diseases; do not make use of food supplements and steroids
Exclusion criteria
Exclusion criteria: Participants who miss more than three training sessions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Capsiate supplementation increased 2.1% of fat-free mass analyzed by bioeletrical impedance and increased 13.4% of upper strength in the bench press in the one maximum repetition. | — |
Secondary
| Measure | Time frame |
|---|---|
| Capsiate supplementation did not decrease fat mass, appetite and inflammatory response. | — |
Countries
Brazil
Contacts
Public ContactFabricio Rossi
Universidade Federal do Piauí
Outcome results
None listed